CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for BioSino Bio-technology and Science Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

BioSino Bio-technology and Science Inc
Changping Business Hotel Opposite,No.27,
Chaoqian Road, Science and Technology
Phone: +86 1080117700p:+86 1080117700 BEIJING, BEJ  102200  China Ticker: 82478247
Business Summary
BIOSINO BIO-TECHNOLOGY AND SCIENCE INCORPORATION is a China-based company principally engaged in the research and development, manufacture, sales and distribution of in-vitro diagnostics reagent products. The Company’s products include mono diagnostic reagent products and double diagnostic reagent products. Its products categories include liver diseases category, kidney diseases category, lipid diseases category, cardiovascular diseases category, glycometabolism category, inorganic ion category, pancreas diseases category and specific protein category. Its products are sold to hospitals and medical institutions.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2022Yes----

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board LebinWu 61 8/3/2020
President, Executive Director PengChen 48 5/25/2023 12/7/2021
Non-Executive Vice Chairman of the Board PengYang 49 9/26/2023 9/26/2023
9 additional Officers and Directors records available in full report.

Business Names
Business Name
8247
Biosino Bio-Technology and Science Inc.

General Information
Number of Employees: 537 (As of 12/31/2023)
Outstanding Shares: 144,707,176 (As of 12/31/2023)
Stock Exchange: HKG
Fax Number: +86 1080117026


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 18, 2024